Anti Mda5 Dermatomyositis Cn378608
A rare autoimmune condition causing muscle inflammation and skin rashes, often associated with severe lung disease. Treatment typically involves immunosuppression.
Key facts at a glance
- ICD-10
- M35.9
- ICD-11
- FA00.0
- Body system
- musculoskeletal
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Interstitial lung disease
Joint pain or stiffness
(musculoskeletal)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Proximal muscle weakness
(musculoskeletal)Mechanic's hands skin change
(integumentary)Arthritis
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dermatomyositis-targeted immunosuppression
Combination of corticosteroids with steroid-sparing agents such as methotrexate or mycophenolate, with consideration for biologics like rituximab in refractory cases. Skin-directed therapy with topical agents complements systemic treatment.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Graduated exercise program
Supervised physical therapy focusing on gentle strengthening, range of motion exercises, and gradual aerobic conditioning to rebuild muscle strength without triggering flares. Essential for functional recovery.
When to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Anti Mda5 Dermatomyositis Cn378608?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Lundberg IE, de Visser M, Werth VP. Classification and management of idiopathic inflammatory myopathies including anti-MDA5 dermatomyositis. Rheumatology. 2022.
Sato S, Kuwana M, Fujita T. Anti-MDA5 antibody-associated dermatomyositis with rapidly progressive interstitial lung disease. Clin Immunol. 2021.
Tsuji H, Nakashima R, Yoshifuji H. Multicenter trial of combination immunosuppressive therapy for rapidly progressive ILD in anti-MDA5 dermatomyositis. Arthritis Rheumatol. 2023.
Matsuda KM, Yoshizaki A, Sato S. Cutaneous manifestations and clinical features of anti-MDA5 dermatomyositis. J Am Acad Dermatol. 2020.
Medication Comparisons
Compare medications used to treat Anti Mda5 Dermatomyositis Cn378608. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy